EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, ELTP: Elite Pharma Inc

17 Oct 2025
LAST:

0.6150

CHANGE:
 0.02		OPEN:
0.6100		HIGH:
0.6199		ASK:
0.4700		VOLUME:
512.6K
CHG(%):
2.53		PREV:
0.5998		LOW:
0.5900		BID:
0.4200		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Oct 250.61000.61990.59000.6150512.6K
16 Oct 250.60260.61000.58410.59981.63M
15 Oct 250.61750.63000.60510.6080755.4K
14 Oct 250.61600.62000.60730.6178603.7K
13 Oct 250.62760.63640.61010.6272714.3K
10 Oct 250.62500.64490.61500.6258822K
09 Oct 250.63000.64470.62000.6316665.1K
08 Oct 250.62630.64490.62270.6332748.1K
07 Oct 250.63750.64000.62850.6370499.3K
06 Oct 250.63500.65000.62510.6281588.4K

COMPANY PROFILE

Name:Elite Pharma Inc
About:Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates through Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals segments. It owns, licenses, manufactures, and sales of generic, oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. In addition, the company provides Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets under the Adderall brand, as well as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release capsules under the Adderall XR brand for central nervous system diseases; Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with sequestered Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the Loxapine brand; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. Additionally, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, attention deficit, and infection. Further, the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey.
Sector:Healthcare
Address:165 Ludlow Avenue, Northvale, NJ, United States, 07647
Website:https://www.elitepharma.com
CUSIP:28659T200
CIK:0001053369
ISIN:US28659T2006
FIGI:BBG000DPZKG9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.610.2%
MA10:0.621.2%
MA20:0.633.2%
MA50:0.632.1%
MA100:0.620.2%
MA200:0.5413.5%
STO9:33.70
STO14:16.08 
RSI14:31.48 
WPR14:-76.58
MTM14:-0.03
ROC14:-0.04 
ATR:0.03 
Week High:0.644.9%
Week Low:0.585.3%
Month High:0.6912.9%
Month Low:0.5813.5%
Year High:0.8233.2%
Year Low:0.27127.8%
Volatility:21.32